ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
28 Oct 2016 06:59

Samsung BioLogics IPO Price Is Set At Highest End (₩136,000) - 3 Points to Consider

Maeil Economic Daily, Korea's largest financial newspaper, has just reported that Samsung BioLogics' IPO price was set at ₩136,000, which is the...

Logo
241 Views
Share
27 Oct 2016 13:11

Samsung BioLogics' Revised Valuation Based on P/B Multiple

In another regulatory filing, Samsung BioLogics presented a revised valuation based on P/B multiple. Obviously, there are still many people who are...

Logo
234 Views
Share
27 Oct 2016 04:46

Pass on the Deal, Put on the Watchlist

This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...

Share
21 Oct 2016 06:54

3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week

Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....

Logo
252 Views
Share
bullishSmartkarma
08 Oct 2016 11:32

Smartkarma - ECM Coverage Weekly Update (10 Oct 2016)

Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:Our accuracy...

Share
x